You Searched For: Spinner+Flasks

Upstream processing for gene therapy Our systems include a wide variety of: Transfection and electroporation products, Viral vector generation kits, Seradigm animal sera (eg., FBS), Single-use products, and Sterile cell factories. Explore solution...

单克隆抗体的上游工艺 开发和制造单克隆抗体已经摆脱了对动物原材料的依赖。我们的生化试剂不含动物成分，以满足这些应用的需要。 为单克隆抗体上游工艺提供的产品用于支持细胞生长，同时满足所需的质量和性能参数。这使得从工艺开发到中试，再到最终的商业制造，实现了无缝过渡。 随着您的流程不断扩大，我们的供应链管理系统可以轻松处理增加的材料数量。一旦您确定了最佳的内部开发生产用基础培养基，我们可以为您定制液体或干燥形式的培养基，并将其包装起来，以便有效地转移到您的生物反应器中。 探索单克隆抗体上游工艺的...

微生物基重组蛋白的上游加工 利用微生物发酵来开发和制造重组蛋白的优势，例如表达不需要翻译后修饰的蛋白，因为像大肠杆菌这样的微生物系统缺乏翻译后机制。 Avantor的产品组合解决了发酵介质和补充剂的需求。 我们的发酵产品支持细胞生长和生产率，同时满足所需的质量和性能参数，允许从研发、试点规模到生产规模的无缝过渡。 主要回收、浓缩和澄清所需的离心机和试剂是可用的。 一旦您的最佳内部开发的生产基础介质确定，期待Avantor定制制造您的液体或干格式的介质，并包装他们，以允许高效转移到您的生物反...

Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Upstream processing for microbial-based recombinant proteins Using microbial fermentation for the development and manufacture of recombinant proteins keeps on showing advantages, e.g for the expression of proteins that do not require post-translat...

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Upstream processing for microbial-based recombinant proteins Using microbial fermentation for the development and manufacture of recombinant proteins keeps on showing advantages e.g for the expression of proteins that do not require post-translati...

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Upstream processing for microbial-based recombinant proteins Using microbial fermentation for the development and manufacture of recombinant proteins keeps on showing advantages e.g for the expression of proteins that do not require post-translati...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines, optimal production is achieved in mammal...

Upstream processing for microbial-based recombinant proteins Using microbial fermentation for the development and manufacture of recombinant proteins keeps on showing advantages e.g for the expression of proteins that do not require post-translati...